Global DNA Vaccines Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global DNA Vaccines market size is predicted to grow from US$ 5261 million in 2025 to US$ 8344 million in 2031; it is expected to grow at a CAGR of 8.0% from 2025 to 2031.
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
LP Information, Inc. (LPI) ' newest research report, the “DNA Vaccines Industry Forecast” looks at past sales and reviews total world DNA Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected DNA Vaccines sales for 2025 through 2031. With DNA Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Vaccines industry.
This Insight Report provides a comprehensive analysis of the global DNA Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DNA Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global DNA Vaccines market?
What factors are driving DNA Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DNA Vaccines market opportunities vary by end market size?
How does DNA Vaccines break out by Type, by Application?
The global DNA Vaccines market size is predicted to grow from US$ 5261 million in 2025 to US$ 8344 million in 2031; it is expected to grow at a CAGR of 8.0% from 2025 to 2031.
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
LP Information, Inc. (LPI) ' newest research report, the “DNA Vaccines Industry Forecast” looks at past sales and reviews total world DNA Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected DNA Vaccines sales for 2025 through 2031. With DNA Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Vaccines industry.
This Insight Report provides a comprehensive analysis of the global DNA Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DNA Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Recombinant Protein Vaccine
- Gene-Based Vaccine
- Human
- Animal
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GSK
- Sanofi
- Zoties
- Elanco
- Boehringer-Ingelheim
- Indian Immunologicals
- Plumbline Life Sciences
What is the 10-year outlook for the global DNA Vaccines market?
What factors are driving DNA Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DNA Vaccines market opportunities vary by end market size?
How does DNA Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global DNA Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for DNA Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for DNA Vaccines by Country/Region, 2020, 2024 & 2031
2.2 DNA Vaccines Segment by Type
2.2.1 Recombinant Protein Vaccine
2.2.2 Gene-Based Vaccine
2.3 DNA Vaccines Sales by Type
2.3.1 Global DNA Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global DNA Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global DNA Vaccines Sale Price by Type (2020-2025)
2.4 DNA Vaccines Segment by Application
2.4.1 Human
2.4.2 Animal
2.5 DNA Vaccines Sales by Application
2.5.1 Global DNA Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global DNA Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global DNA Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global DNA Vaccines Breakdown Data by Company
3.1.1 Global DNA Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global DNA Vaccines Sales Market Share by Company (2020-2025)
3.2 Global DNA Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global DNA Vaccines Revenue by Company (2020-2025)
3.2.2 Global DNA Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global DNA Vaccines Sale Price by Company
3.4 Key Manufacturers DNA Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers DNA Vaccines Product Location Distribution
3.4.2 Players DNA Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DNA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic DNA Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global DNA Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global DNA Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic DNA Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global DNA Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global DNA Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas DNA Vaccines Sales Growth
4.4 APAC DNA Vaccines Sales Growth
4.5 Europe DNA Vaccines Sales Growth
4.6 Middle East & Africa DNA Vaccines Sales Growth
5 AMERICAS
5.1 Americas DNA Vaccines Sales by Country
5.1.1 Americas DNA Vaccines Sales by Country (2020-2025)
5.1.2 Americas DNA Vaccines Revenue by Country (2020-2025)
5.2 Americas DNA Vaccines Sales by Type (2020-2025)
5.3 Americas DNA Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DNA Vaccines Sales by Region
6.1.1 APAC DNA Vaccines Sales by Region (2020-2025)
6.1.2 APAC DNA Vaccines Revenue by Region (2020-2025)
6.2 APAC DNA Vaccines Sales by Type (2020-2025)
6.3 APAC DNA Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe DNA Vaccines by Country
7.1.1 Europe DNA Vaccines Sales by Country (2020-2025)
7.1.2 Europe DNA Vaccines Revenue by Country (2020-2025)
7.2 Europe DNA Vaccines Sales by Type (2020-2025)
7.3 Europe DNA Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa DNA Vaccines by Country
8.1.1 Middle East & Africa DNA Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa DNA Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa DNA Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa DNA Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of DNA Vaccines
10.3 Manufacturing Process Analysis of DNA Vaccines
10.4 Industry Chain Structure of DNA Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 DNA Vaccines Distributors
11.3 DNA Vaccines Customer
12 WORLD FORECAST REVIEW FOR DNA VACCINES BY GEOGRAPHIC REGION
12.1 Global DNA Vaccines Market Size Forecast by Region
12.1.1 Global DNA Vaccines Forecast by Region (2026-2031)
12.1.2 Global DNA Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global DNA Vaccines Forecast by Type (2026-2031)
12.7 Global DNA Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck DNA Vaccines Product Portfolios and Specifications
13.1.3 Merck DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK DNA Vaccines Product Portfolios and Specifications
13.2.3 GSK DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi DNA Vaccines Product Portfolios and Specifications
13.3.3 Sanofi DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Zoties
13.4.1 Zoties Company Information
13.4.2 Zoties DNA Vaccines Product Portfolios and Specifications
13.4.3 Zoties DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Zoties Main Business Overview
13.4.5 Zoties Latest Developments
13.5 Elanco
13.5.1 Elanco Company Information
13.5.2 Elanco DNA Vaccines Product Portfolios and Specifications
13.5.3 Elanco DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Elanco Main Business Overview
13.5.5 Elanco Latest Developments
13.6 Boehringer-Ingelheim
13.6.1 Boehringer-Ingelheim Company Information
13.6.2 Boehringer-Ingelheim DNA Vaccines Product Portfolios and Specifications
13.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boehringer-Ingelheim Main Business Overview
13.6.5 Boehringer-Ingelheim Latest Developments
13.7 Indian Immunologicals
13.7.1 Indian Immunologicals Company Information
13.7.2 Indian Immunologicals DNA Vaccines Product Portfolios and Specifications
13.7.3 Indian Immunologicals DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Indian Immunologicals Main Business Overview
13.7.5 Indian Immunologicals Latest Developments
13.8 Plumbline Life Sciences
13.8.1 Plumbline Life Sciences Company Information
13.8.2 Plumbline Life Sciences DNA Vaccines Product Portfolios and Specifications
13.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Plumbline Life Sciences Main Business Overview
13.8.5 Plumbline Life Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. DNA Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. DNA Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant Protein Vaccine
Table 4. Major Players of Gene-Based Vaccine
Table 5. Global DNA Vaccines Sales byType (2020-2025) & (K Units)
Table 6. Global DNA Vaccines Sales Market Share byType (2020-2025)
Table 7. Global DNA Vaccines Revenue byType (2020-2025) & ($ million)
Table 8. Global DNA Vaccines Revenue Market Share byType (2020-2025)
Table 9. Global DNA Vaccines Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global DNA Vaccines Sale by Application (2020-2025) & (K Units)
Table 11. Global DNA Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global DNA Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global DNA Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global DNA Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global DNA Vaccines Sales by Company (2020-2025) & (K Units)
Table 16. Global DNA Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global DNA Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global DNA Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global DNA Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers DNA Vaccines Producing Area Distribution and Sales Area
Table 21. Players DNA Vaccines Products Offered
Table 22. DNA Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global DNA Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global DNA Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global DNA Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global DNA Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global DNA Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global DNA Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global DNA Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global DNA Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas DNA Vaccines Sales by Country (2020-2025) & (K Units)
Table 34. Americas DNA Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas DNA Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas DNA Vaccines Sales byType (2020-2025) & (K Units)
Table 37. Americas DNA Vaccines Sales by Application (2020-2025) & (K Units)
Table 38. APAC DNA Vaccines Sales by Region (2020-2025) & (K Units)
Table 39. APAC DNA Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC DNA Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC DNA Vaccines Sales byType (2020-2025) & (K Units)
Table 42. APAC DNA Vaccines Sales by Application (2020-2025) & (K Units)
Table 43. Europe DNA Vaccines Sales by Country (2020-2025) & (K Units)
Table 44. Europe DNA Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe DNA Vaccines Sales byType (2020-2025) & (K Units)
Table 46. Europe DNA Vaccines Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa DNA Vaccines Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa DNA Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa DNA Vaccines Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa DNA Vaccines Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of DNA Vaccines
Table 52. Key Market Challenges & Risks of DNA Vaccines
Table 53. Key IndustryTrends of DNA Vaccines
Table 54. DNA Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. DNA Vaccines Distributors List
Table 57. DNA Vaccines Customer List
Table 58. Global DNA Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global DNA Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas DNA Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas DNA Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC DNA Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC DNA Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe DNA Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe DNA Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa DNA Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa DNA Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global DNA Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 69. Global DNA Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global DNA Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global DNA Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck DNA Vaccines Product Portfolios and Specifications
Table 74. Merck DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GSK Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK DNA Vaccines Product Portfolios and Specifications
Table 79. GSK DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Sanofi Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi DNA Vaccines Product Portfolios and Specifications
Table 84. Sanofi DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Zoties Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Zoties DNA Vaccines Product Portfolios and Specifications
Table 89. Zoties DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Zoties Main Business
Table 91. Zoties Latest Developments
Table 92. Elanco Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Elanco DNA Vaccines Product Portfolios and Specifications
Table 94. Elanco DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Elanco Main Business
Table 96. Elanco Latest Developments
Table 97. Boehringer-Ingelheim Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer-Ingelheim DNA Vaccines Product Portfolios and Specifications
Table 99. Boehringer-Ingelheim DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Boehringer-Ingelheim Main Business
Table 101. Boehringer-Ingelheim Latest Developments
Table 102. Indian Immunologicals Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Indian Immunologicals DNA Vaccines Product Portfolios and Specifications
Table 104. Indian Immunologicals DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Indian Immunologicals Main Business
Table 106. Indian Immunologicals Latest Developments
Table 107. Plumbline Life Sciences Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Plumbline Life Sciences DNA Vaccines Product Portfolios and Specifications
Table 109. Plumbline Life Sciences DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Plumbline Life Sciences Main Business
Table 111. Plumbline Life Sciences Latest Developments
LIST OFFIGURES
Figure 1. Picture of DNA Vaccines
Figure 2. DNA Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global DNA Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global DNA Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. DNA Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. DNA Vaccines Sales Market Share by Country/Region (2024)
Figure 10. DNA Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Recombinant Protein Vaccine
Figure 12. Product Picture of Gene-Based Vaccine
Figure 13. Global DNA Vaccines Sales Market Share byType in 2025
Figure 14. Global DNA Vaccines Revenue Market Share byType (2020-2025)
Figure 15. DNA Vaccines Consumed in Human
Figure 16. Global DNA Vaccines Market: Human (2020-2025) & (K Units)
Figure 17. DNA Vaccines Consumed in Animal
Figure 18. Global DNA Vaccines Market: Animal (2020-2025) & (K Units)
Figure 19. Global DNA Vaccines Sale Market Share by Application (2024)
Figure 20. Global DNA Vaccines Revenue Market Share by Application in 2025
Figure 21. DNA Vaccines Sales by Company in 2025 (K Units)
Figure 22. Global DNA Vaccines Sales Market Share by Company in 2025
Figure 23. DNA Vaccines Revenue by Company in 2025 ($ millions)
Figure 24. Global DNA Vaccines Revenue Market Share by Company in 2025
Figure 25. Global DNA Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global DNA Vaccines Revenue Market Share by Geographic Region in 2025
Figure 27. Americas DNA Vaccines Sales 2020-2025 (K Units)
Figure 28. Americas DNA Vaccines Revenue 2020-2025 ($ millions)
Figure 29. APAC DNA Vaccines Sales 2020-2025 (K Units)
Figure 30. APAC DNA Vaccines Revenue 2020-2025 ($ millions)
Figure 31. Europe DNA Vaccines Sales 2020-2025 (K Units)
Figure 32. Europe DNA Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa DNA Vaccines Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa DNA Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Americas DNA Vaccines Sales Market Share by Country in 2025
Figure 36. Americas DNA Vaccines Revenue Market Share by Country (2020-2025)
Figure 37. Americas DNA Vaccines Sales Market Share byType (2020-2025)
Figure 38. Americas DNA Vaccines Sales Market Share by Application (2020-2025)
Figure 39. United States DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC DNA Vaccines Sales Market Share by Region in 2025
Figure 44. APAC DNA Vaccines Revenue Market Share by Region (2020-2025)
Figure 45. APAC DNA Vaccines Sales Market Share byType (2020-2025)
Figure 46. APAC DNA Vaccines Sales Market Share by Application (2020-2025)
Figure 47. China DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. India DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe DNA Vaccines Sales Market Share by Country in 2025
Figure 55. Europe DNA Vaccines Revenue Market Share by Country (2020-2025)
Figure 56. Europe DNA Vaccines Sales Market Share byType (2020-2025)
Figure 57. Europe DNA Vaccines Sales Market Share by Application (2020-2025)
Figure 58. Germany DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59.France DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. UK DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa DNA Vaccines Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa DNA Vaccines Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa DNA Vaccines Sales Market Share by Application (2020-2025)
Figure 66. Egypt DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of DNA Vaccines in 2025
Figure 72. Manufacturing Process Analysis of DNA Vaccines
Figure 73. Industry Chain Structure of DNA Vaccines
Figure 74. Channels of Distribution
Figure 75. Global DNA Vaccines Sales MarketForecast by Region (2026-2031)
Figure 76. Global DNA Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global DNA Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 78. Global DNA Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global DNA Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global DNA Vaccines Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global DNA Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for DNA Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for DNA Vaccines by Country/Region, 2020, 2024 & 2031
2.2 DNA Vaccines Segment by Type
2.2.1 Recombinant Protein Vaccine
2.2.2 Gene-Based Vaccine
2.3 DNA Vaccines Sales by Type
2.3.1 Global DNA Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global DNA Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global DNA Vaccines Sale Price by Type (2020-2025)
2.4 DNA Vaccines Segment by Application
2.4.1 Human
2.4.2 Animal
2.5 DNA Vaccines Sales by Application
2.5.1 Global DNA Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global DNA Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global DNA Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global DNA Vaccines Breakdown Data by Company
3.1.1 Global DNA Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global DNA Vaccines Sales Market Share by Company (2020-2025)
3.2 Global DNA Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global DNA Vaccines Revenue by Company (2020-2025)
3.2.2 Global DNA Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global DNA Vaccines Sale Price by Company
3.4 Key Manufacturers DNA Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers DNA Vaccines Product Location Distribution
3.4.2 Players DNA Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DNA VACCINES BY GEOGRAPHIC REGION
4.1 World Historic DNA Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global DNA Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global DNA Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic DNA Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global DNA Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global DNA Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas DNA Vaccines Sales Growth
4.4 APAC DNA Vaccines Sales Growth
4.5 Europe DNA Vaccines Sales Growth
4.6 Middle East & Africa DNA Vaccines Sales Growth
5 AMERICAS
5.1 Americas DNA Vaccines Sales by Country
5.1.1 Americas DNA Vaccines Sales by Country (2020-2025)
5.1.2 Americas DNA Vaccines Revenue by Country (2020-2025)
5.2 Americas DNA Vaccines Sales by Type (2020-2025)
5.3 Americas DNA Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DNA Vaccines Sales by Region
6.1.1 APAC DNA Vaccines Sales by Region (2020-2025)
6.1.2 APAC DNA Vaccines Revenue by Region (2020-2025)
6.2 APAC DNA Vaccines Sales by Type (2020-2025)
6.3 APAC DNA Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe DNA Vaccines by Country
7.1.1 Europe DNA Vaccines Sales by Country (2020-2025)
7.1.2 Europe DNA Vaccines Revenue by Country (2020-2025)
7.2 Europe DNA Vaccines Sales by Type (2020-2025)
7.3 Europe DNA Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa DNA Vaccines by Country
8.1.1 Middle East & Africa DNA Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa DNA Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa DNA Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa DNA Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of DNA Vaccines
10.3 Manufacturing Process Analysis of DNA Vaccines
10.4 Industry Chain Structure of DNA Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 DNA Vaccines Distributors
11.3 DNA Vaccines Customer
12 WORLD FORECAST REVIEW FOR DNA VACCINES BY GEOGRAPHIC REGION
12.1 Global DNA Vaccines Market Size Forecast by Region
12.1.1 Global DNA Vaccines Forecast by Region (2026-2031)
12.1.2 Global DNA Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global DNA Vaccines Forecast by Type (2026-2031)
12.7 Global DNA Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck DNA Vaccines Product Portfolios and Specifications
13.1.3 Merck DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK DNA Vaccines Product Portfolios and Specifications
13.2.3 GSK DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi DNA Vaccines Product Portfolios and Specifications
13.3.3 Sanofi DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Zoties
13.4.1 Zoties Company Information
13.4.2 Zoties DNA Vaccines Product Portfolios and Specifications
13.4.3 Zoties DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Zoties Main Business Overview
13.4.5 Zoties Latest Developments
13.5 Elanco
13.5.1 Elanco Company Information
13.5.2 Elanco DNA Vaccines Product Portfolios and Specifications
13.5.3 Elanco DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Elanco Main Business Overview
13.5.5 Elanco Latest Developments
13.6 Boehringer-Ingelheim
13.6.1 Boehringer-Ingelheim Company Information
13.6.2 Boehringer-Ingelheim DNA Vaccines Product Portfolios and Specifications
13.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boehringer-Ingelheim Main Business Overview
13.6.5 Boehringer-Ingelheim Latest Developments
13.7 Indian Immunologicals
13.7.1 Indian Immunologicals Company Information
13.7.2 Indian Immunologicals DNA Vaccines Product Portfolios and Specifications
13.7.3 Indian Immunologicals DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Indian Immunologicals Main Business Overview
13.7.5 Indian Immunologicals Latest Developments
13.8 Plumbline Life Sciences
13.8.1 Plumbline Life Sciences Company Information
13.8.2 Plumbline Life Sciences DNA Vaccines Product Portfolios and Specifications
13.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Plumbline Life Sciences Main Business Overview
13.8.5 Plumbline Life Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. DNA Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. DNA Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant Protein Vaccine
Table 4. Major Players of Gene-Based Vaccine
Table 5. Global DNA Vaccines Sales byType (2020-2025) & (K Units)
Table 6. Global DNA Vaccines Sales Market Share byType (2020-2025)
Table 7. Global DNA Vaccines Revenue byType (2020-2025) & ($ million)
Table 8. Global DNA Vaccines Revenue Market Share byType (2020-2025)
Table 9. Global DNA Vaccines Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global DNA Vaccines Sale by Application (2020-2025) & (K Units)
Table 11. Global DNA Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global DNA Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global DNA Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global DNA Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global DNA Vaccines Sales by Company (2020-2025) & (K Units)
Table 16. Global DNA Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global DNA Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global DNA Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global DNA Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers DNA Vaccines Producing Area Distribution and Sales Area
Table 21. Players DNA Vaccines Products Offered
Table 22. DNA Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global DNA Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global DNA Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global DNA Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global DNA Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global DNA Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global DNA Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global DNA Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global DNA Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas DNA Vaccines Sales by Country (2020-2025) & (K Units)
Table 34. Americas DNA Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas DNA Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas DNA Vaccines Sales byType (2020-2025) & (K Units)
Table 37. Americas DNA Vaccines Sales by Application (2020-2025) & (K Units)
Table 38. APAC DNA Vaccines Sales by Region (2020-2025) & (K Units)
Table 39. APAC DNA Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC DNA Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC DNA Vaccines Sales byType (2020-2025) & (K Units)
Table 42. APAC DNA Vaccines Sales by Application (2020-2025) & (K Units)
Table 43. Europe DNA Vaccines Sales by Country (2020-2025) & (K Units)
Table 44. Europe DNA Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe DNA Vaccines Sales byType (2020-2025) & (K Units)
Table 46. Europe DNA Vaccines Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa DNA Vaccines Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa DNA Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa DNA Vaccines Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa DNA Vaccines Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of DNA Vaccines
Table 52. Key Market Challenges & Risks of DNA Vaccines
Table 53. Key IndustryTrends of DNA Vaccines
Table 54. DNA Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. DNA Vaccines Distributors List
Table 57. DNA Vaccines Customer List
Table 58. Global DNA Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global DNA Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas DNA Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas DNA Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC DNA Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC DNA Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe DNA Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe DNA Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa DNA Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa DNA Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global DNA Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 69. Global DNA Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global DNA Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global DNA Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck DNA Vaccines Product Portfolios and Specifications
Table 74. Merck DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GSK Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK DNA Vaccines Product Portfolios and Specifications
Table 79. GSK DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Sanofi Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi DNA Vaccines Product Portfolios and Specifications
Table 84. Sanofi DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Zoties Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Zoties DNA Vaccines Product Portfolios and Specifications
Table 89. Zoties DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Zoties Main Business
Table 91. Zoties Latest Developments
Table 92. Elanco Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Elanco DNA Vaccines Product Portfolios and Specifications
Table 94. Elanco DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Elanco Main Business
Table 96. Elanco Latest Developments
Table 97. Boehringer-Ingelheim Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer-Ingelheim DNA Vaccines Product Portfolios and Specifications
Table 99. Boehringer-Ingelheim DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Boehringer-Ingelheim Main Business
Table 101. Boehringer-Ingelheim Latest Developments
Table 102. Indian Immunologicals Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Indian Immunologicals DNA Vaccines Product Portfolios and Specifications
Table 104. Indian Immunologicals DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Indian Immunologicals Main Business
Table 106. Indian Immunologicals Latest Developments
Table 107. Plumbline Life Sciences Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Plumbline Life Sciences DNA Vaccines Product Portfolios and Specifications
Table 109. Plumbline Life Sciences DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Plumbline Life Sciences Main Business
Table 111. Plumbline Life Sciences Latest Developments
LIST OFFIGURES
Figure 1. Picture of DNA Vaccines
Figure 2. DNA Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global DNA Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global DNA Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. DNA Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. DNA Vaccines Sales Market Share by Country/Region (2024)
Figure 10. DNA Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Recombinant Protein Vaccine
Figure 12. Product Picture of Gene-Based Vaccine
Figure 13. Global DNA Vaccines Sales Market Share byType in 2025
Figure 14. Global DNA Vaccines Revenue Market Share byType (2020-2025)
Figure 15. DNA Vaccines Consumed in Human
Figure 16. Global DNA Vaccines Market: Human (2020-2025) & (K Units)
Figure 17. DNA Vaccines Consumed in Animal
Figure 18. Global DNA Vaccines Market: Animal (2020-2025) & (K Units)
Figure 19. Global DNA Vaccines Sale Market Share by Application (2024)
Figure 20. Global DNA Vaccines Revenue Market Share by Application in 2025
Figure 21. DNA Vaccines Sales by Company in 2025 (K Units)
Figure 22. Global DNA Vaccines Sales Market Share by Company in 2025
Figure 23. DNA Vaccines Revenue by Company in 2025 ($ millions)
Figure 24. Global DNA Vaccines Revenue Market Share by Company in 2025
Figure 25. Global DNA Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global DNA Vaccines Revenue Market Share by Geographic Region in 2025
Figure 27. Americas DNA Vaccines Sales 2020-2025 (K Units)
Figure 28. Americas DNA Vaccines Revenue 2020-2025 ($ millions)
Figure 29. APAC DNA Vaccines Sales 2020-2025 (K Units)
Figure 30. APAC DNA Vaccines Revenue 2020-2025 ($ millions)
Figure 31. Europe DNA Vaccines Sales 2020-2025 (K Units)
Figure 32. Europe DNA Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa DNA Vaccines Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa DNA Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Americas DNA Vaccines Sales Market Share by Country in 2025
Figure 36. Americas DNA Vaccines Revenue Market Share by Country (2020-2025)
Figure 37. Americas DNA Vaccines Sales Market Share byType (2020-2025)
Figure 38. Americas DNA Vaccines Sales Market Share by Application (2020-2025)
Figure 39. United States DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC DNA Vaccines Sales Market Share by Region in 2025
Figure 44. APAC DNA Vaccines Revenue Market Share by Region (2020-2025)
Figure 45. APAC DNA Vaccines Sales Market Share byType (2020-2025)
Figure 46. APAC DNA Vaccines Sales Market Share by Application (2020-2025)
Figure 47. China DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. India DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe DNA Vaccines Sales Market Share by Country in 2025
Figure 55. Europe DNA Vaccines Revenue Market Share by Country (2020-2025)
Figure 56. Europe DNA Vaccines Sales Market Share byType (2020-2025)
Figure 57. Europe DNA Vaccines Sales Market Share by Application (2020-2025)
Figure 58. Germany DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59.France DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. UK DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa DNA Vaccines Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa DNA Vaccines Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa DNA Vaccines Sales Market Share by Application (2020-2025)
Figure 66. Egypt DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries DNA Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of DNA Vaccines in 2025
Figure 72. Manufacturing Process Analysis of DNA Vaccines
Figure 73. Industry Chain Structure of DNA Vaccines
Figure 74. Channels of Distribution
Figure 75. Global DNA Vaccines Sales MarketForecast by Region (2026-2031)
Figure 76. Global DNA Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global DNA Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 78. Global DNA Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global DNA Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global DNA Vaccines Revenue Market ShareForecast by Application (2026-2031)
More Publications
Potential Analysis of Human DNA Vaccines Market by Forecast Scenario Analysis (Rapid Growth Scenario, Moderate Growth Scenario, and Low Growth Scenario) - Global Opportunity Analysis and Industry Forecast, 2020-2030
US$ 4,999.00
June 2017
120 pages
Global DNA Vaccination Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
73 pages
